N/a Injection
Product Images NDC 71053-591

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for N/a (NDC 71053-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rafa Laboratories, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atropine 0.5 mg Unit Label (0.5mg Unit)

Atropine 0.5 mg Unit Label (0.5mg Unit)
Atropine Injection is available as an auto-injector which delivers 0.42 mg Atropine equivalent to 0.5 mg Atropine Sulfate. It is for intramuscular use only and is a prescription-based medication. It comes with a yellow safety cap that needs to be removed before use. The green tip of the injector needs to be aimed and firmly jabbed against the outer thigh for 10 seconds. It is manufactured by Rafa Laboratories in Jerusalem, Israel. The product needs to be stored at a temperature between 15 to 30 degrees Celsius. The lot and Expiration details are not available. NDC number for Atropine Injection is 71053590016.*
FDA Label Image

Atropine 1 mg Unit Label (1mg Unit)

Atropine 1 mg Unit Label (1mg Unit)
ATROPINE INJECTION 1 mg/0.7 ml (AUTO-INJECTOR) is a prescription medication used for injection intramuscularly only in case of nerve agent and insecticide poisoning. Each auto-injector contains 0.84 mg of Atropine, equivalent to 1 mg of Atropine Sulfate. The product is distributed with three NDC 71053591013 and a lot number and expiration date. To use, remove the yellow safety cap and aim the green tip against the outer thigh for ten seconds. Storage of the injection should be at 25°C (77°F), but can tolerate excursions to 15-30°C (59-86°F). The medication is manufactured by Rafa Laboratories in Jerusalem, Israel.*
FDA Label Image

Atropine 01

FDA Label Image

Atropine 02

Atropine 02
This is a set of instructions outlining the steps to follow when deciding the appropriate number of Atropine autoinjectors to administer to someone who has been exposed to a chemical agent. The instructions include information on how to decide if the 2mg autoinjector is suitable for the exposed person based on weight and age, how to determine if symptoms are mild or severe using Table 1, and how many autoinjectors to use based on the severity of symptoms. The instructions also provide guidance on how to administer multiple autoinjectors if severe symptoms persist after the first injection.*
FDA Label Image

Atropine 03

FDA Label Image

Atropine 04

Atropine 04
This appears to be a label or tag with limited information. The text mentions a "Yellow Safety Cap" and a "Green Tip" but without additional context, it is unclear what product or item this label is attached to. Therefore, the description is not-available.*
FDA Label Image

Atropine 05

FDA Label Image

Atropine 06

FDA Label Image

Atropine 07

FDA Label Image

Atropine 08

FDA Label Image

Atropine 09

FDA Label Image

Atropine 10

Atropine 10
This is an Autoinjector of Atropine Injection 2mg/0.7mL used for intramuscular administration. It is an Rx only medication and is used as a treatment for nerve agent and insecticide poisoning. The autoinjector delivers 1.67mg Atropine, equivalent to 2mg Atropine Sulfate. It has an NSN number of 6505-31-017-0350 and is manufactured by Rafa Laboratories in Jerusalem, Israel. It is essential to store the medication at 20°C to 25°C (68°F to 77°F) and should not be frozen. The lot number and expiry date are not provided. The package contains 480 units. Seeing the prescribing information is important.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.